Persona Ti-Nidium Post-Market Clinical Follow-up
Persona Ti-Nidium Post-Market Clinical Follow-up
Active, not recruiting · NCT04817969 · Registry updated 2026-09-22Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Persona Ti-Nidium Post-Market Clinical Follow-up | Necrosis, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Skin and Connective Tissue Diseases, arthritic joint disease, arthropathy, autoimmune disease, avascular necrosis, bone disorder, connective tissue disorder, immune system disorder, musculoskeletal system disorder, osteoarthritis, osteonecrosis, polyarticular arthritis, rheumatic disorder, rheumatoid arthritis | Active, not recruiting | Not applicable | 2026-09-22 | NCT04817969 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Zimmer Biomet | 71 |
7 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Denver Hip & Knee, Inc. | Parker | United States | 1 |
| Duke University | Durham | United States | 45 |
| MedStar Health Research Institute | Hyattsville | United States | 11 |
| Mississippi Sports Medicine and Orthopaedic Center | Jackson | United States | 2 |
| Monument Health Rapid City Hospital, Inc. | Rapid City | United States | 2 |
| New Mexico Orthopaedic Associates | Albuquerque | United States | 2 |
| Rothman Orthopaedic Institute | Philadelphia | United States | 11 |